Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 6/20 | 0.65 |
| ▸ | CA1 | P00915 | 2/20 | 0.54 |
| ▸ | CA9 | Q16790 | 2/20 | 0.54 |
| ▸ | CA5A | P35218 | 1/20 | 0.54 |
| ▸ | MAOA | P21397 | 1/20 | 0.54 |
| ▸ | MAOB | P27338 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | MGLL | Q99685 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6378860 | 0.98 | CA2 (0.68) | CA2CA1CA9CA5AMAOA | |
| SCHEMBL1837364 | 0.98 | CA2 (0.68) | CA2CA1CA9CA5AMAOA | |
| SCHEMBL1793990 | 0.94 | CA2 (0.72) | CA2CA1CA9CA5AMAOA | |
| SCHEMBL4061411 | 0.92 | CA2 (0.70) | CA2CA1CA9CA5AMAOA | |
| SCHEMBL1644097 | 0.85 | CA2 (0.70) | CA2CA1CA9CA5A | |
| Hydrochloric Acid SCHEMBL3516882 | 0.83 | CA2 (0.68) | CA2CA1CA9CA5AMAOA | |
| SCHEMBL4063879 | 0.83 | CA2 (0.68) | CA2CA1CA9CA5A | |
| SCHEMBL10899010 | 0.83 | CA2 (0.63) | CA2MAOAMAOBMEN1KMT2A | |
| SCHEMBL293285 | 0.81 | MAOB (0.54) | CA2MAOAMAOBMEN1KMT2A | |
| SCHEMBL293286 | 0.79 | MEN1 (0.53) | CA2MAOAMEN1KMT2AMGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4148775-A | POLYAMIDE COPOLYMER, TERPENE-PHENOL RESIN, PLASTICIZER | DAICEL LTD. (JP) | 1979-04-10 | — | — | US | claimed |
| US-20230399322-A1 | EIF4E INHIBITORS AND USES THEREOF | PIC Therapeutics, Inc. | 2023-12-14 | — | — | US | disclosed |
| US-11753403-B2 | EIF4E inhibitors and uses thereof | PIC Therapeutics, Inc. (US) | 2023-09-12 | — | — | US | disclosed |
| CN-115667384-A | Multilayer structure based on recycled polyamide | 阿科玛法国公司 | 2023-01-31 | — | — | CN | disclosed |
| EP-4011871-A2 | PROCESSES FOR PREPARING OXATHIAZIN-LIKE COMPOUNDS | Geistlich Pharma AG (CH) | 2022-06-15 | — | — | EP | disclosed |
| US-10800917-B2 | Reactive blends of nylon and anhydride oligomer | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2020-10-13 | — | — | US | disclosed |
| US-20180327590-A1 | Reactive Blends of Nylon and Anhydride Oligomer | EXXONMOBIL CHEMICAL PATENTS INC. | 2018-11-15 | — | — | US | disclosed |
| CN-107922362-A | 1,3, 4-oxadiazole sulfonamide derivative compounds as histone deacetylase 6 inhibitors and pharmaceutical compositions containing the same | 株式会社钟根堂 | 2018-04-17 | — | — | CN | disclosed |
| CN-101784520-B | Novel malonic acid sulfonamide derivative and pharmaceutical use thereof | MITSUBISHI TANABE PHARMA CORP | 2014-07-02 | — | — | CN | disclosed |
| US-8461209-B2 | Malonic acid sulfonamide derivative and pharmaceutical use thereof | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2013-06-11 | — | — | US | disclosed |
| US-4923890-A | Difluoro keto compounds and their use as HLE inhibitors | ICI AMERICAS INC. (US) | 1990-05-08 | — | — | US | disclosed |
| US-4910190-A | Containing a nitrogen containing heterocycle ring structure | ICI AMERICAS INC. (US) | 1990-03-20 | — | — | US | disclosed |
| US-4880780-A | RESPIRATORY SYSTEM DISORDERS | ICI AMERICAS INC. (US) | 1989-11-14 | — | — | US | disclosed |
| US-4873221-A | Difluoro peptide compounds | ICI AMERICAS INC. (US) | 1989-10-10 | — | — | US | disclosed |
| EP-0276101-A2 | Substituted peptide derivatives | ICI AMERICAS INC. (US) | 1988-07-27 | — | — | EP | disclosed |
| EP-0249349-A1 | Difluoroketo compounds | ICI AMERICAS INC. (US) | 1987-12-16 | — | — | EP | disclosed |
| EP-0248562-A2 | Difluoro peptide compounds | ZENECA INC. (US) | 1987-12-09 | — | — | EP | disclosed |
| EP-0204571-A2 | Selected difluoro derivatives | ICI AMERICAS INC. (US) | 1986-12-10 | — | — | EP | disclosed |
| EP-0189305-A2 | Peptide derivatives | ICI AMERICAS INC. (US) | 1986-07-30 | — | — | EP | disclosed |
| US-4148775-A | POLYAMIDE COPOLYMER, TERPENE-PHENOL RESIN, PLASTICIZER | DAICEL LTD. (JP) | 1979-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230399322-A1 | EIF4E INHIBITORS AND USES THEREOF | EIF4E, EIF4EBP1, EIF4A1 | CA2 3669/4885CA1 4317/4885CA9 4088/4885 |
| US-11753403-B2 | EIF4E inhibitors and uses thereof | EIF4E, EIF4EBP1, EIF4A1 | CA2 3669/4885CA1 4317/4885CA9 4088/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.